4D Bioprinting with Smart Biomedical Materials: Current Challenges and Future Directions

Works and Collections MDPI EBB Ability to print high- viscosity bioinks, scalable for larger constructs Bone, cartilage, and vascular tissues (Noroozi et al., 2023; Gara et al., 2025) Springer LAB Precise cell placement, high resolution, minimal nozzle clogging Skin grafts, nerve regeneration (Jose et al., 2026) MDPI ֍SLAB Excellent structural fidelity, rapid prototyping Complex tissue scaffolds (Ramakrishnan & Dinesan, 2025) Taylor & Francis eBooks, Reference Works and Collections †4D-B Stimuli-responsive materials, dynamic tissue adaptation Smart implants, personalized medicine (Noroozi et al., 2023; Gara et al., 2025) Springer ֍Stereolithography Bioprinting , †4D Bioprinting 2.4 Applications of 4D Bioprinting The integration of smart materials and advanced bioprinting technologies has opened new avenues in biomedical research and clinical practice. They include tissue engineering such as dynamic scaffolds that grow and remodel with host tissue. In drug delivery such as constructs that release therapeutics in response to physiological signals. Soft robotics is another practice like bioactuators capable of movement and adaptation. In personalized medicine, patient-specific implants are developed to adjust and respond effectively within biological environments (EngiSphere Research Editors, 2025). Despite its promise, 4D bioprinting faces several challenges: Material limitations: Developing biocompatible smart materials that balance mechanical strength and biological functionality. Complexity of stimuli control: Ensuring precise, reproducible responses in clinical environments. Ethical and regulatory concerns: Addressing safety, long- term stability, and patient-specific risks. Future prospects include integrating artificial intelligence (AI) and digital twins to simulate tissue behavior, enabling predictive modeling and optimization of bioprinted constructs (EngiSphere Research Editors, 2025). 4D bioprinting represents a paradigm shift in biomedical engineering, moving beyond static constructs to dynamic, adaptive systems. By leveraging smart materials and stimuli-responsive technologies, it offers unprecedented opportunities in tissue engineering, drug delivery, and regenerative medicine. While challenges remain, ongoing research continues to push the boundaries of what is possible, bringing us closer to the realization of living, functional bioprinted tissues. 3.0 Smart Biomedical Materials Smart biomedical materials represent a new frontier in biomedical engineering, offering dynamic properties that respond to external stimuli such as temperature, pH, light, or mechanical stress. Unlike traditional biomaterials, these advanced materials can adapt, self-heal, or degrade in controlled ways, making them highly suitable for applications in tissue engineering, regenerative medicine, and drug delivery. Key categories include shape memory polymers, hydrogels and stimuli-responsive biomaterials, nanocomposites and bioactive scaffolds, and biodegradable/bioresorbable materials (as seen in Fig. 2). Figure 2: Schematic representing smart features utilized in designing smart biomaterials for various biomedical applications (Raheem et al., 2025). 3.1 Shape Memory Polymers Shape memory polymers are synthetic materials capable of returning to a pre-defined shape when exposed to specific stimuli, most commonly heat or light. Their biocompatibility, flexibility, and tunable mechanical properties make them ideal for minimally invasive medical devices, stents, and orthopedic applications (Rokaya et al., 2023). SMPs can be temporarily deformed and later recover their original shape, which is particularly useful in self-expanding implants. Recent advances in SMP nanocomposites have improved their mechanical strength and responsiveness, broadening their biomedical applications in cardiovascular stents and tissue scaffolds (Zheng et al., 2024). 3.2 Hydrogels and Stimuli-Responsive Biomaterials Hydrogels are hydrophilic polymer networks that can absorb large amounts of water, closely mimicking the extracellular matrix of biological tissues. Their softness and biocompatibility make them suitable for wound healing, drug delivery, and regenerative medicine. Stimuli- responsive hydrogels, also known as “smart hydrogels,” can swell, shrink, or change shape in response to environmental cues such as pH, temperature, or light (MDPI, 2024). For example, pH-sensitive hydrogels can release drugs in acidic tumor environments, while thermo-responsive hydrogels can undergo phase transitions at body temperature. These properties enable precise control over drug release and tissue integration, making hydrogels indispensable in modern biomedical applications. 3.3 Nanocomposites and Bioactive Scaffolds Nanocomposites combine polymers with nanoparticles to enhance mechanical, electrical, or biological properties. In biomedical engineering, nanocomposites improve scaffold strength, promote cell adhesion, and enable controlled drug release. For instance, incorporating hydroxyapatite nanoparticles into polymer scaffolds enhances osteoconductivity, making them suitable for bone regeneration (Zheng et al., 2024). Bioactive scaffolds are designed to interact with biological systems by promoting cell growth and tissue integration. They often incorporate bioactive molecules or nanoparticles to stimulate cellular responses. These scaffolds are particularly valuable in regenerative medicine, where they serve as temporary structures that guide tissue formation before being resorbed or replaced by natural tissue. 3.4 Biodegradable and Bioresorbable Materials Biodegradable materials are engineered to break down into non-toxic byproducts within the body, eliminating the need for surgical removal. Common examples include polylactic acid and polyglycolic acid , which are widely used in sutures, drug delivery systems, and temporary implants (Rokaya et al., 2023). Bioresorbable materials go further by being metabolized and absorbed by the body. These materials are particularly valuable in cardiovascular stents and orthopedic implants, where gradual resorption supports tissue healing while reducing long-term complications. Their controlled degradation rates ensure mechanical support during healing before safely disappearing, aligning with the body’s natural processes. 3.5 Applications and Future Prospects Smart biomedical materials are increasingly applied in: • Tissue engineering: Dynamic scaffolds that adapt to biological environments. • Drug delivery: Stimuli-responsive systems that release therapeutics at targeted sites. • Implantable devices: SMP-based stents and bioresorbable implants that reduce surgical risks. • Regenerative medicine: Hydrogels and bioactive scaffolds that mimic natural tissue environments. Smart biomedical materials such as SMPs, hydrogels, nanocomposites, and biodegradable scaffolds represent a paradigm shift in biomedical engineering. Their adaptability, biocompatibility, and responsiveness to stimuli make them indispensable in regenerative medicine, drug delivery, and implantable devices. As research advances, these materials will continue to transform healthcare by enabling more effective, personalized, and minimally invasive treatments. 4.0 Stimuli for 4D Bioprinting 4D bioprinting extends the capabilities of 3D bioprinting by introducing the dimension of time, enabling constructs to adapt, transform, or respond to external stimuli. This dynamic behavior is achieved through the use of stimuli-responsive smart materials, which allow bioprinted structures to mimic the adaptability of living tissues. Key stimuli include thermal, pH, magnetic, electrical, and biochemical triggers, all of which play crucial roles in biomedical applications (Kim et al., 2024). 4.1 Thermal Triggers Thermal stimuli are widely used in 4D bioprinting due to their ability to activate shape-memory polymers and thermo-responsive hydrogels. SMPs can be deformed at lower temperatures and recover their original shape upon heating, making them ideal for self- expanding implants and scaffolds. Thermo-responsive hydrogels undergo phase transitions near body temperature, enabling controlled drug release and tissue remodeling (Bhandari et al., 2026). 4.2 pH Triggers pH-sensitive materials respond to changes in acidity or alkalinity, making them particularly useful in biomedical contexts. Hydrogels that swell or shrink in response to pH variations can release drugs in acidic tumor environments or inflamed tissues. This property allows for site- specific therapeutic delivery, reducing systemic side effects and enhancing treatment efficacy (Kim et al., 2024). 4.3 Magnetic Triggers Magneto-responsive materials incorporate magnetic nanoparticles, enabling constructs to be manipulated remotely using external magnetic fields. These materials can undergo shape changes, movement, or controlled drug release when exposed to magnetic stimuli. Magnetic responsiveness is especially valuable in targeted therapies and minimally invasive biomedical applications, such as guiding scaffolds to specific tissue sites (Mathur et al., 2025). 4.4 Electrical Triggers Electrical stimuli can modulate the behavior of conductive polymers and hydrogels. These materials change shape, stiffness, or permeability when exposed to electrical fields. Electrical responsiveness is particularly relevant in neural tissue engineering and bioelectronics, where constructs must interact with electrical signals in the body. This integration supports the development of smart implants and bioelectronic interfaces (Bhandari et al., 2026). 4.5 Biochemical Triggers Biochemical stimuli involve responses to enzymes, proteins, or other biological molecules. For instance, enzyme-sensitive hydrogels degrade in the presence of specific enzymes, enabling controlled drug release or scaffold remodeling. Biochemical triggers allow bioprinted constructs to integrate seamlessly with biological processes, enhancing their functionality in vivo (Mathur et al., 2025). 4.6 Integration with Physiological Environments The effectiveness of 4D bioprinting depends on the ability of stimuli-responsive materials to integrate with physiological environments. Smart biomaterials must be biocompatible, non-toxic, and capable of responding to stimuli within the body’s natural ranges. For example: • Thermal triggers must align with body temperature fluctuations. • pH-responsive systems must adapt to variations in tissue microenvironments. • Biochemical triggers must respond selectively to enzymes or proteins present in specific tissues. This integration ensures that 4D bioprinted constructs can function effectively in clinical applications, mimicking the dynamic behavior of living tissues (Kim et al., 2024). Stimuli such as thermal, pH, magnetic, electrical, and biochemical triggers form the foundation of 4D bioprinting, enabling constructs to adapt dynamically within physiological environments. By integrating these stimuli-responsive materials with biological systems, 4D bioprinting offers transformative potential in tissue engineering, regenerative medicine, and drug delivery. As research advances, these technologies will continue to revolutionize biomedicine by creating adaptive, patient-specific solutions. 5.0 Applications of 4D Bioprinting in Biomedicine 4D bioprinting builds upon the foundation of 3D bioprinting by introducing the dimension of time, enabling constructs to adapt, transform, or respond to external stimuli. This dynamic capability allows bioprinted tissues and scaffolds to mimic the behavior of living systems more closely. The integration of stimuli-responsive smart materials with physiological environments has opened new avenues in tissue engineering, regenerative medicine, drug delivery, personalized implants, and organ-on-chip systems (Eskizengin & Ergun, 2025). 5.1.0 Tissue Engineering 5.1.1 Bone Bone tissue engineering benefits significantly from 4D bioprinting. Smart scaffolds incorporating hydroxyapatite nanoparticles and shape-memory polymers can remodel in response to mechanical stimuli, promoting osteogenesis. These constructs provide structural support while adapting to bone growth and healing processes (Liu et al., 2026). 5.1.2 Cartilage Cartilage repair requires materials that can withstand mechanical stress while maintaining elasticity. Stimuli-responsive hydrogels are particularly useful, as they can adapt to compressive forces and mimic the viscoelastic properties of cartilage. This adaptability enhances integration with native tissue and supports long-term regeneration (Eskizengin & Ergun, 2025). 5.1.3 Vascular Vascular tissue engineering relies on scaffolds that can expand, contract, or remodel in response to biochemical signals. 4D bioprinting enables the creation of dynamic vascular grafts that respond to blood flow and biochemical cues, supporting angiogenesis and vascular remodeling. This is crucial for developing functional vascular networks in engineered tissues (Liu et al., 2026). 5.2 Regenerative Medicine In regenerative medicine, 4D bioprinting offers scaffolds that evolve alongside host tissues. Constructs can self-heal, remodel, or degrade in response to biological signals, reducing the need for repeated interventions. For example, enzyme-sensitive hydrogels degrade selectively in vivo, allowing tissue regeneration to progress naturally. This adaptability enhances patient outcomes by providing long-term support for tissue repair (Eskizengin & Ergun, 2025). 5.3 Drug Delivery Systems Stimuli-responsive materials are particularly valuable in drug delivery. Hydrogels and nanocomposites can release drugs in response to pH, temperature, or enzymatic activity, ensuring targeted and controlled release. For instance, pH-sensitive hydrogels can release chemotherapeutics in acidic tumor environments, while thermo-responsive systems can deliver drugs at body temperature. This precision reduces systemic side effects and improves therapeutic efficacy (Liu et al., 2026). 5.4 Personalized Implants and Prosthetics 4D bioprinting enables the creation of implants and prosthetics tailored to individual patients. Shape-memory polymer-based stents can expand in response to body temperature, while bioresorbable scaffolds degrade as tissues heal. These personalized devices adapt to patient- specific physiological conditions, enhancing comfort and reducing complications. Prosthetics incorporating smart materials can also adjust to mechanical stress, improving functionality and patient mobility (Eskizengin & Ergun, 2025). 5.5 Organ-on-Chip and Disease Modeling Organ-on-chip systems benefit from 4D bioprinting by incorporating dynamic, stimuli- responsive materials that mimic physiological processes. These systems can replicate disease progression, drug responses, and tissue remodeling, providing valuable platforms for research and personalized medicine. For example, vascularized organ-on-chip models can simulate blood flow and biochemical signaling, enabling more accurate disease modeling and drug testing (Liu et al., 2026). 4D bioprinting represents a paradigm shift in biomedicine, moving beyond static constructs to dynamic, adaptive systems. Applications in tissue engineering, regenerative medicine, drug delivery, personalized implants, and organ-on-chip systems highlight its transformative potential. By leveraging stimuli-responsive materials and integrating them with physiological environments, 4D bioprinting offers unprecedented opportunities to create patient-specific solutions that closely mimic the complexity of living systems. As research advances, these technologies are poised to revolutionize healthcare by enabling more effective, personalized, and minimally invasive treatments. 6.0 Technological Integration in 4D Bioprinting 4D bioprinting represents a transformative leap in biomedical engineering, enabling constructs to adapt dynamically over time in response to external stimuli. While the foundation lies in smart biomaterials, the true potential of 4D bioprinting is realized through technological integration. Advances in artificial intelligence (AI), robotics and automation, and imaging with real-time monitoring are reshaping the field, making bioprinting more precise, scalable, and clinically relevant (Pugliese & Regondi, 2022). 6.1 AI and Computational Modeling in 4D Bioprinting Artificial intelligence plays a pivotal role in optimizing 4D bioprinting processes. AI algorithms can analyze vast datasets to predict material behavior, cellular responses, and construct evolution over time. Computational modeling allows researchers to simulate tissue growth, scaffold remodeling, and drug release dynamics before actual printing, reducing trial-and-error experimentation (Tamir et al., 2025). For example: • Predictive modeling: AI can forecast how stimuli-responsive materials will behave under physiological conditions, ensuring constructs adapt as intended. • Design optimization: Machine learning algorithms can refine scaffold architectures for mechanical strength and biological compatibility. • Personalized medicine: AI-driven models can tailor bioprinted constructs to patient-specific data, enabling individualized implants and therapies (Pugliese & Regondi, 2022). By integrating AI, 4D bioprinting becomes more efficient, reducing costs and accelerating clinical translation. 6.2 Robotics and Automation Robotics and automation are essential for scaling 4D bioprinting from laboratory research to clinical applications. Automated bioprinting platforms ensure reproducibility, precision, and high throughput, which are critical for manufacturing complex tissues and organs. Key contributions include: • Precision handling: Robotic arms can manipulate bioinks and scaffolds with micron-level accuracy, reducing variability. • High-throughput production: Automation enables the simultaneous fabrication of multiple constructs, supporting mass customization for patient-specific implants. • Integration with smart materials: Robotics can coordinate stimuli application (e.g., heat, magnetic fields) during printing, ensuring constructs evolve correctly (Liu et al., 2025). Robotics also facilitate minimally invasive procedures, where bioprinted constructs can be delivered and activated directly within the body, enhancing clinical applicability. 6.3 Imaging and Real-Time Monitoring Imaging technologies and real-time monitoring are critical for ensuring the fidelity and functionality of 4D bioprinted constructs. Advanced imaging modalities such as optical coherence tomography , confocal microscopy, and magnetic resonance imaging allow researchers to visualize construct development and cellular integration. Applications include: • Quality assurance: Real-time monitoring ensures that printed constructs match design specifications, reducing defects. • Dynamic tracking: Imaging can monitor scaffold remodeling, drug release, and tissue integration over time. • Feedback systems: Coupling imaging with AI enables closed-loop control, where printing parameters are adjusted in real time based on observed outcomes (Tamir et al., 2025). This integration ensures that bioprinted constructs are not only structurally accurate but also biologically functional, supporting long-term clinical success. 6.4 Synergistic Integration The true potential of 4D bioprinting lies in the synergy between AI, robotics, and imaging: • AI provides predictive models and design optimization. • Robotics ensures precise, automated fabrication. • Imaging validates construct fidelity and guides adaptive adjustments. Together, these technologies create a feedback-driven ecosystem where bioprinted constructs can be designed, fabricated, and monitored with unprecedented accuracy and adaptability (Liu et al., 2025). Technological integration is the cornerstone of advancing 4D bioprinting from experimental research to clinical practice. AI and computational modeling enhance predictive accuracy and personalization, robotics and automation ensure precision and scalability, and imaging with real-time monitoring validates construct functionality. By combining these technologies, 4D bioprinting is poised to revolutionize biomedicine, enabling dynamic, patient- specific solutions that closely mimic the complexity of living systems. 7.0 Challenges and Limitations of 4D Bioprinting 4D bioprinting represents a revolutionary advancement in biomedical engineering, enabling constructs to adapt dynamically over time in response to external stimuli. While the technology holds immense promise for tissue engineering, regenerative medicine, and personalized healthcare, it faces significant challenges that hinder its widespread adoption. Key limitations include biocompatibility and safety, scalability and reproducibility, regulatory and ethical considerations, and cost and accessibility (Ramezani & Ripin, 2023). 7.1 Biocompatibility and Safety One of the foremost challenges in 4D bioprinting is ensuring the biocompatibility of smart materials used in constructs. Stimuli-responsive polymers, hydrogels, and nanocomposites must interact seamlessly with biological systems without eliciting adverse immune responses. However, many smart materials are synthetic and may degrade into toxic byproducts, raising safety concerns (Appuhamillage et al., 2024). For example: • Shape-memory polymers may release harmful residues during degradation. • Nanocomposites incorporating metallic nanoparticles risk cytotoxicity and oxidative stress. • Hydrogels must balance mechanical strength with biocompatibility, which is often difficult to achieve. Moreover, long-term safety remains uncertain, as constructs must function dynamically within the body for extended periods. Ensuring predictable degradation rates and non-toxic byproducts is critical for clinical translation (Ramezani & Ripin, 2023). 7.2 Scalability and Reproducibility Another major limitation is the scalability and reproducibility of 4D bioprinting processes. While laboratory-scale experiments have demonstrated success, translating these constructs into clinically viable products remains challenging. 7.2.1 Scalability Issues • Complex stimuli-responsive materials are difficult to mass-produce with consistent quality. • Large-scale constructs, such as organs or vascular networks, require precise control over material properties and stimuli responses. • Integration of multiple cell types and biomaterials increases complexity, making industrial- scale production difficult (Appuhamillage et al., 2024). 7.2.2 Reproducibility Challenges Reproducibility is critical for clinical applications, yet 4D bioprinting often suffers from variability in material behavior. Small changes in environmental conditions (temperature, pH, or magnetic fields) can significantly alter construct performance. This variability undermines reliability and hinders regulatory approval (Ramezani & Ripin, 2023). 7.3 Regulatory and Ethical Considerations The regulatory landscape for 4D bioprinting is still evolving. Unlike traditional medical devices, 4D bioprinted constructs are dynamic and adaptive, complicating safety assessments and approval processes. 7.3.1 Regulatory Challenges • Current frameworks are designed for static implants and devices, not dynamic constructs. • Long-term monitoring of adaptive implants is required, but standardized protocols are lacking. • Ensuring reproducibility and safety across diverse patient populations complicates approval (Appuhamillage et al., 2024). 7.3.2 Ethical Considerations Ethical concerns also arise in 4D bioprinting: • Patient consent: Patients must understand that implants may change shape or function over time. • Equity: Advanced technologies risk widening healthcare disparities if only accessible to wealthy populations. • Identity and autonomy: Adaptive prosthetics and implants may raise questions about human enhancement and the boundaries between natural and artificial biology (Ramezani & Ripin, 2023). These considerations highlight the need for robust ethical frameworks and transparent communication with patients and stakeholders. 7.4 Cost and Accessibility Cost remains a significant barrier to widespread adoption of 4D bioprinting. The technology requires specialized equipment, advanced biomaterials, and highly skilled personnel, all of which contribute to high expenses. 7.4.1 Cost Drivers • Smart materials: Stimuli-responsive polymers and nanocomposites are expensive to synthesize and process. • Equipment: Advanced bioprinters with robotic automation and imaging systems are costly. • Research and development: Extensive testing and optimization increase financial burdens (Appuhamillage et al., 2024). 7.4.2 Accessibility Challenges High costs limit accessibility, particularly in low- and middle-income countries. Without affordable solutions, 4D bioprinting risks becoming an exclusive technology available only to elite healthcare institutions. Ensuring equitable access requires cost-reduction strategies, such as open-source designs, material innovations, and scalable manufacturing techniques (Ramezani & Ripin, 2023). 4D bioprinting holds transformative potential in biomedicine, offering dynamic, adaptive constructs for tissue engineering, regenerative medicine, drug delivery, and personalized healthcare. However, significant challenges remain. Ensuring biocompatibility and safety, achieving scalability and reproducibility, addressing regulatory and ethical concerns, and overcoming cost and accessibility barriers are critical for clinical translation. Addressing these limitations requires interdisciplinary collaboration among material scientists, engineers, clinicians, ethicists, and policymakers. As research advances, overcoming these challenges will be essential to unlock the full potential of 4D bioprinting in revolutionizing healthcare. 8.0 Future Directions of 4D Bioprinting As seen in Fig. 3, 4D bioprinting has emerged as a transformative technology in biomedical engineering, building upon 3D bioprinting by introducing the dimension of time. This advancement allows bioprinted constructs to adapt, remodel, or respond to external stimuli, mimicking the dynamic behavior of living tissues. While current applications have demonstrated promise in tissue engineering and regenerative medicine, the future of 4D bioprinting lies in its integration with advanced biomedical technologies and sustainable practices. Key directions include self-adaptive implants, integration with nanomedicine and gene therapy, clinical translation pathways, and sustainable bioprinting practices (Alanazia et al., 2025; Noroozi et al., 2023). Fig. 3: Graphical illustration of future directions of 4D bioprinting: sustainable bioprinting practices, nanomedicine and gene therapy, clinical translation pathways and self-adaptive implants. 8.1 Self-Adaptive Implants One of the most promising future directions of 4D bioprinting is the development of self- adaptive implants. Unlike static implants, these constructs can respond to physiological changes, adjusting their shape, stiffness, or biochemical properties in real time. For example, shape- memory polymers and stimuli-responsive hydrogels can expand, contract, or degrade in response to body temperature, pH, or enzymatic activity (Alanazia et al., 2025). Self-adaptive implants could revolutionize orthopedics, cardiovascular medicine, and prosthetics: • Orthopedics: Bone scaffolds that remodel in response to mechanical stress, promoting natural bone regeneration. • Cardiovascular medicine: Stents that expand or contract dynamically to maintain vascular patency. • Prosthetics: Adaptive prosthetic interfaces that adjust to patient movement, improving comfort and functionality. These implants would reduce the need for revision surgeries and enhance patient-specific outcomes, marking a significant leap toward personalized medicine. 8.2 Integration with Nanomedicine and Gene Therapy Another critical future direction is the integration of 4D bioprinting with nanomedicine and gene therapy. Nanotechnology enables the incorporation of nanoparticles into bioprinted constructs, enhancing mechanical strength, drug delivery, and cellular interactions. For instance, nanocomposite scaffolds can release therapeutic agents in response to stimuli, providing localized treatment for cancer or infections (Noroozi et al., 2023). Gene therapy integration further expands possibilities: • Gene-activated scaffolds: Bioprinted constructs embedded with vectors that deliver therapeutic genes to surrounding tissues. • Controlled gene expression: Stimuli-responsive materials can regulate gene release, ensuring precise therapeutic outcomes. • Regenerative applications: Combining gene therapy with bioprinted scaffolds could accelerate tissue regeneration by promoting stem cell differentiation and growth factor production (Alanazia et al., 2025). Together, nanomedicine and gene therapy integration will enable multifunctional bioprinted constructs capable of both structural support and therapeutic intervention. 8.2 Clinical Translation Pathways Despite its promise, 4D bioprinting faces challenges in clinical translation. Future directions must focus on establishing robust pathways for clinical adoption, including standardized protocols, regulatory frameworks, and interdisciplinary collaboration. 8.2.1 Standardization Developing standardized bioinks, printing parameters, and stimuli-responsive materials is essential for reproducibility. Without consistency, clinical approval and widespread adoption remain difficult (Noroozi et al., 2023). 8.2.2 Regulatory Frameworks Current medical device regulations are designed for static implants, not dynamic constructs. Future regulatory frameworks must account for adaptive behavior, long-term monitoring, and patient-specific variability. This requires collaboration between scientists, clinicians, and policymakers (Alanazia et al., 2025). 8.2.3 Interdisciplinary Collaboration Clinical translation will depend on collaboration across disciplines: • Material scientists to develop biocompatible smart materials. • Engineers to refine printing technologies. • Clinicians to validate safety and efficacy in patient populations. Such collaboration will accelerate the transition of 4D bioprinting from laboratory research to clinical practice. 8.3 Sustainable Bioprinting Practices As 4D bioprinting advances, sustainability will become increasingly important. The production of smart biomaterials and advanced bioprinters requires significant resources, raising concerns about environmental impact and accessibility. 8.3.1 Eco-Friendly Materials Future research should focus on developing biodegradable and bioresorbable smart materials that minimize waste and environmental harm. Natural polymers such as alginate, chitosan, and collagen offer sustainable alternatives to synthetic polymers (Noroozi et al., 2023). 8.3.2 Energy Efficiency Bioprinting processes must be optimized for energy efficiency. Robotics and automation can reduce resource consumption by minimizing errors and waste during fabrication (Alanazia et al., 2025). 8.3.3 Accessibility Sustainable practices also involve ensuring equitable access to 4D bioprinting technologies. Cost-reduction strategies, open-source designs, and scalable manufacturing methods will be critical to prevent disparities in healthcare access. The future of 4D bioprinting lies in its ability to create dynamic, patient-specific solutions that integrate seamlessly with biological systems. Self-adaptive implants will transform prosthetics and implants, while integration with nanomedicine and gene therapy will enable multifunctional constructs with therapeutic capabilities. Establishing clinical translation pathways will ensure safety, reproducibility, and regulatory approval, while sustainable bioprinting practices will address environmental and accessibility concerns. By advancing these directions, 4D bioprinting is poised to revolutionize biomedicine, offering adaptive, personalized, and sustainable solutions for the future of healthcare. 9.0 Conclusion 9.1 Summary of Impact 4D bioprinting has emerged as a groundbreaking advancement in biomedical engineering, extending the capabilities of 3D bioprinting by introducing adaptability and responsiveness over time. Unlike static constructs, 4D bioprinted materials can evolve, remodel, or respond to external stimuli such as temperature, pH, magnetic fields, electrical signals, or biochemical cues. This dynamic functionality allows bioprinted tissues and scaffolds to more closely mimic the complexity of living systems. The impact of 4D bioprinting is already evident across multiple domains. In tissue engineering, it enables scaffolds that grow and remodel alongside host tissues, supporting bone, cartilage, and vascular regeneration. In regenerative medicine, adaptive constructs reduce the need for repeated interventions by self-healing or degrading in response to biological signals. In drug delivery, stimuli-responsive hydrogels and nanocomposites provide precise, targeted release, minimizing systemic side effects. Furthermore, personalized implants and prosthetics benefit from adaptability, enhancing patient comfort and reducing complications. Finally, organ-on-chip systems leverage 4D bioprinting to replicate disease progression and drug responses, offering powerful platforms for research and personalized medicine. Collectively, these applications highlight the transformative potential of 4D bioprinting in creating patient-specific, dynamic solutions that bridge the gap between artificial constructs and natural biology. 9.2 Outlook for the Next Decade Looking ahead, the next decade will likely see 4D bioprinting transition from experimental research to clinical practice. Several key trends will shape this evolution: • Self-adaptive implants will become more common, particularly in orthopedics and cardiovascular medicine, where constructs can adjust to mechanical stress or vascular changes. • Integration with nanomedicine and gene therapy will enable multifunctional bioprinted constructs that not only provide structural support but also deliver therapeutic agents or regulate gene expression. • Clinical translation pathways will mature, with standardized bioinks, reproducible protocols, and regulatory frameworks tailored to dynamic implants. Interdisciplinary collaboration among scientists, engineers, clinicians, and policymakers will be essential to ensure safety and efficacy. • Sustainable bioprinting practices will gain prominence, focusing on eco-friendly biomaterials, energy-efficient processes, and equitable access to advanced technologies. By 2036, 4D bioprinting is expected to play a central role in personalized medicine, offering adaptive, patient-specific solutions that reduce healthcare costs and improve outcomes. While challenges remain—such as biocompatibility, scalability, and regulatory approval—the trajectory of research suggests that 4D bioprinting will revolutionize biomedicine, ushering in an era where living, evolving constructs become integral to healthcare. 10. Conflict of Interests The author declares that there is no conflict of interests regarding the publication of this paper. Reference AccScience Publishing. (2025). Smart materials for 4D bioprinting. AccScience Special Issue. Retrieved from https://accscience.com Alanazi, B. N., Ahmed, H. A., Alharbi, N. S., Ebrahim, N. A. A., & Soliman, S. M. A. (2025). Exploring 4D printing of smart materials for regenerative medicine applications. RSC Advances, 15(32), 32155–32171. https://doi.org/10.1039/D5RA04410C Appuhamillage, G. A., Ambagaspitiya, S. S., Dassanayake, R. S., & Wijenayake, A. (2024). 3D and 4D printing of biomedical materials: Current trends, challenges, and future outlook. Exploration of Medicine, 5(17–47). https://doi.org/10.37349/emed.2024.00203 Arif, Z., Khalid, M. Y., Ahmed, W., & Arshad, H. (2022). A review on four-dimensional (4D) bioprinting in pursuit of advanced tissue engineering applications. Bioprinting, e00203. https://doi.org/10.1016/j.bprint.2022.e00203 Bhandari, A., Ghosh, R. N., Namboothiri, P. K., & Peter, M. (2026). A review of stimuli- responsive materials in 4D bioprinting for biomedical applications. Materials Advances, 7(17), 1–20. https://doi.org/10.1039/D6MA00123A EngiSphere Research Editors. (2025, August 25). 4D Bioprinting: The next leap in living materials. Retrieved from https://engisphere.com Eskizengin, H., & Ergun, C. (2025). Advancements and applications of 4D bioprinting in biomedical science. Chinese Journal of Polymer Science, 43(1), 18–39. https://doi.org/10.1007/s10118-024-00001-9 Gara, D. K., Gujjala, R., Prasad, P. S., Madaboosi, N., & Ojha, S. (2025). 4D bioprinting: A review on smart bio-adaptable technology to print stimuli-responsive materials. Progress in Additive Manufacturing, 10(4375–4417). Springer Nature. https://springer.com Jose, S. A., Evtimow, A., & Menezes, P. L. (2026). Advances in 3D bioprinting: Materials, processes, and emerging applications. Micromachines, 17(3), 282. https://doi.org/10.3390/mi17030282 Kim, J., Debnath, P., & Saha, P. (2024). Smart multi-responsive biomaterials and their applications for 4D bioprinting. Biomimetics,9(8), 484. https://doi.org/10.3390/biomimetics9080484 Liu, G., Wu, J., Yang, Y., Luo, J., & Xie, X. (2026). 4D printing in regenerative medicine: Bio- inspired applications for dynamic tissue repair. Journal of Functional Biomaterials, 17(2), 72. https://doi.org/10.3390/jfb17020072 Liu, J., Wang, Q., Xu, K., Li, Z., & Liu, J. (2025). AI-enhanced magnetically controlled 4D printing: Reshaping the future of medical robotics. International Journal of Bioprinting. https://doi.org/10.36922/IJB025420427 Mathur, V., Agarwal, P., Kasturi, M., Varadharajan, S., Devi, E. S., & Vasanthan, K. S. (2025). Transformative bioprinting: 4D printing and its role in the evolution of engineering and personalized medicine. Discover Nano. https://doi.org/10.1007/s44161-025-00001 MDPI. (2024). Shape memory hydrogels for biomedical applications. Journal of Composites Science, 7(1), 24. https://www.mdpi.com Noroozi, R., Arif, Z. U., Taghvaei, H., Khalid, M. Y., Sahbafar, H., Hadi, A., Sadeghianmaryan, A., & Chen, X. (2023). 3D and 4D bioprinting technologies: A game changer for the biomedical sector? Annals of Biomedical Engineering, 51(1683–1712). https://doi.org/10.1007/s10439-023-03123-7 Pugliese, R., & Regondi, S. (2022). Artificial intelligence-empowered 3D and 4D printing technologies toward smarter biomedical materials and approaches. Polymers, 14(14), 2794. https://doi.org/10.3390/polym14142794 Raheem, A., Mandal, K., Biswas, S., Ahari, A., Najafabadi, A. H., Farhadi, N., Zehtabi, F., Gangrade, A., Mecwan, M., Maity, S., Sharma, S., Arputharaj, J. N., Khan, P. A., Udduttula, A., Kouchehbaghi, N. H., Khorsandi, D., Vasita, R., Haghniaz, R., Herculano, R. D., John, J. V., Kim, H., Dokmeci, M. R., Popat, K. C., Zhu, Y., & Manivasagam, G. (2025). Smart biomaterials in healthcare: Breakthroughs in tissue engineering, immunomodulation, patient-specific therapies, and biosensor applications. Applied Physics Reviews, 12(1), 011333. https://doi.org/10.1063/5.0238817 Ramakrishnan, R., & Dinesan, A. (2025). Advantages and disadvantages of 3D bioprinting. In Compendium of 3D Bioprinting Technology (pp. 30–45). CRC Press. Ramezani, M., & Ripin, Z. M. (2023). 4D printing in biomedical engineering: Advancements, challenges, and future directions. Journal of Functional Biomaterials, 14(7), 347. https://doi.org/10.3390/jfb14070347 Rokaya, D., Skallevold, H. E., Srimaneepong, V., Marya, A., Shah, P. K., Khurshid, Z., Zafar, M. S., & Sapkota, J. (2023). Shape memory polymeric materials for biomedical applications: An update. Journal of Composites Science, 7(1), 24. https://www.mdpi.com Tamir, T. S., Teferi, F. B., Hua, X., Leng, J., Xiong, G., Shen, Z., & Liu, Q. (2025). A review of advances in 3D and 4D bioprinting: Toward mass individualization paradigm. Journal of Intelligent Manufacturing, 36(12), 5217–5246. https://doi.org/10.1007/s10845-024- 01567-9 Zheng, Y., Du, Y., Chen, L., Mao, W., Pu, Y., Wang, S., & Wang, D. (2024). Recent advances in shape memory polymeric nanocomposites for biomedical applications and beyond. Biomaterials.